SCHEMBL2350199

SCHEMBL2350199

CCCCCCCCC(C)(CCCCCCCC)C([O])=O

nearest known ligand 0.47

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CES2 O00748 4/20 0.47
GGPS1 O95749 6/20 0.45
FDPS P14324 9/20 0.43
CES1 P23141 3/20 0.42
LPAR1 Q92633 1/20 0.42
LPAR3 Q9UBY5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2349543 0.90 FDPS (0.38) CES2FDPSCES1
SCHEMBL20853966 0.81 CES2 (0.47) CES2GGPS1
SCHEMBL20854577 0.81 CES2 (0.47) CES2GGPS1
SCHEMBL20853973 0.81 CES2 (0.47) CES2GGPS1
SCHEMBL25272453 0.81 CES2 (0.47) CES2GGPS1
SCHEMBL25272931 0.81 CES2 (0.47) CES2GGPS1
SCHEMBL20853817 0.81 CES2 (0.47) CES2GGPS1
SCHEMBL20854006 0.81 CES2 (0.47) CES2GGPS1
SCHEMBL20854582 0.81 CES2 (0.47) CES2GGPS1
SCHEMBL20853888 0.81 CES2 (0.47) CES2GGPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078724-B1 PROCESS FOR PRODUCTION OF DIALKYLTIN DIALKOXIDES ASAHI CHEMICAL IND (JP) 2016-11-30 EP disclosed
US-8008518-B2 Process for producing dialkyl tin dialkoxides ASAHI KASEI CHEMICALS CORPORATION (JP) 2011-08-30 US disclosed
US-20100041908-A1 PROCESS FOR PRODUCING DIALKYL TIN DIALKOXIDES ASAHI KASEI KABUSHIKI KAISHA (JP) 2010-02-18 US disclosed
EP-2078724-A1 PROCESS FOR PRODUCTION OF DIALKYLTIN DIALKOXIDES Asahi Kasei Chemicals Corporation (JP) 2009-07-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041908-A1 PROCESS FOR PRODUCING DIALKYL TIN DIALKOXIDES DEK, DDT, DERA CES2 717/4885GGPS1 714/4885FDPS 86/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.